• Acetoacetate (Ketones), Serum
  • 5-AMP-Activated Protein Kinase, Gamma-2 Subunit (PRKAG2) Mutation Analysis
  • Acute pain
  • Diffuse large B-cell lymphoma
  • BRAF Gene Mutation Analysis
  • Methadone and Metabolites, Confirmation, Urine
  • Fluvoxamine, Urine
  • Triiodothyronine (T3), Total
  • Noonan Spectrum Disorders Gene Mutation Panel, NGS
  • Apolipoprotein E (Apo E) Genotyping
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Clostridium difficile (C. Diff) by Molecular Method
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Clostridium difficile (C. Diff) by Molecular Method
Medical Test

Turnaround Time
Access to Clostridium difficile (C. Diff) by Molecular Method is restricted.